A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

NCT04184466 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Clamp Study

Interventions

DRUG: Insulin Aspart
DRUG: NovoRapid® Penfill®

Sponsor

Geropharm